Intervention not reported
Adverse events · individuals with HL
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life · individuals with HL
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Treatment related mortality · individuals with HL
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
CRC Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention leads to lower CRC Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review
Intervention not reported
CRC Mortality ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to lower CRC Mortality ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
CRC incidence ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention probably leads to lower CRC incidence ‐ Flexible sigmoidoscopy (moderate certainty).
1 finding from 1 review
Intervention not reported
CRC incidence ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to lower CRC incidence ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention showed no clear difference in all‐cause Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to higher all‐cause Mortality ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
HIV infection · High‐risk HIV‐uninfected individuals (including serodiscordant couples, men who have sex with men and sex workers)
TDF+ FTC probably leads to lower HIV infection compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · High‐risk HIV‐uninfected individuals (including serodiscordant couples, men who have sex with men and sex workers)
TDF+ FTC showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
HIV infection · High‐risk individuals (including serodiscordant couples, men who have sex with men and sex workers)
TDF probably leads to lower HIV infection compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · High‐risk individuals (including serodiscordant couples, men who have sex with men and sex workers)
TDF showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
It is very uncertain whether d4T changes mortality compared with AZT (very low certainty).
1 finding from 1 review
Clinical progression · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in clinical progression compared with AZT (low certainty).
1 finding from 1 review
Severe adverse events · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in severe adverse events compared with AZT (low certainty).
1 finding from 1 review
Virologic response · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in virologic response compared with AZT (low certainty).
1 finding from 1 review
Adherence/tolerability/retention · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
d4T showed no clear difference in adherence/tolerability/retention compared with AZT (low certainty).
1 finding from 1 review
Immunologic response · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
1 finding from 1 review
Drug resistance · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
It is very uncertain whether d4T changes drug resistance compared with AZT (very low certainty).
1 finding from 1 review